HMO formularies and care costs

被引:12
作者
RossDegnan, D [1 ]
Soumerai, SB [1 ]
机构
[1] HARVARD PILGRIM HLTH CARE,BOSTON,MA 02215
关键词
D O I
10.1016/S0140-6736(96)90782-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1264 / 1264
页数:1
相关论文
共 4 条
[1]   EFFECTS OF MEDICAID DRUG-PAYMENT LIMITS ON ADMISSION TO HOSPITALS AND NURSING-HOMES [J].
SOUMERAI, SB ;
ROSSDEGNAN, D ;
AVORN, J ;
MCLAUGHLIN, TJ ;
CHOODNOVSKIY, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (15) :1072-1077
[2]   A CRITICAL ANALYSIS OF STUDIES OF STATE DRUG REIMBURSEMENT POLICIES - RESEARCH IN NEED OF DISCIPLINE [J].
SOUMERAI, SB ;
ROSSDEGNAN, D ;
FORTESS, EE ;
ABELSON, J .
MILBANK QUARTERLY, 1993, 71 (02) :217-252
[3]   EFFECTS OF LIMITING MEDICAID DRUG-REIMBURSEMENT BENEFITS ON THE USE OF PSYCHOTROPIC AGENTS AND ACUTE MENTAL-HEALTH-SERVICES BY PATIENTS WITH SCHIZOPHRENIA [J].
SOUMERAI, SB ;
MCLAUGHLIN, TJ ;
ROSSDEGNAN, D ;
CASTERIS, CS ;
BOLLINI, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (10) :650-655
[4]   WITHDRAWING PAYMENT FOR NONSCIENTIFIC DRUG-THERAPY - INTENDED AND UNEXPECTED EFFECTS OF A LARGE-SCALE NATURAL EXPERIMENT [J].
SOUMERAI, SB ;
ROSSDEGNAN, D ;
GORTMAKER, S ;
AVORN, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (06) :831-839